Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases

Rheumatology

Volumn 49, Issue 7, 2010, Pages 1239-1244

  Maiti, Amit K ^a   Kim Howard, Xana ^a   Viswanathan, Parvathi ^a   Guillén, Laura ^b   Qian, Xiaoxia ^c   Rojas Villarraga, Adriana ^d   Sun, Celi ^a   Cañas, Carlos ^e   Tobón, Gabriel J ^e   Matsuda, Koichi ^f   Shen, Nan ^c   Cherñavsky, Alejandra C ^b   Anaya, Juan Manuel ^d   Nath, Swapan K ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Unidad de Biología Celular y Molecular   (Colombia)

^e FUNDACIÓN VALLE DEL LILI   (Colombia)

^f THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Asia; Autoimmunity; CD226; Latin America

Indexed keywords

CD226 PROTEIN; CHROMOSOME PROTEIN; UNCLASSIFIED DRUG;

ARGENTINA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CAUCASIAN; CELIAC DISEASE; CHINA; COLOMBIA; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARGENTINA; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; COLOMBIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; STATISTICS AS TOPIC;

EID: 77954208061     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep470     Document Type: Article

References (44)

1. Deshmukh H, Kim-Howard X, Nath SK. Replication of recently identified associated SNPs from 6 autoimmune diseases in GAW16 RA data. BMC Proc 2009; Suppl. 7:831.
2. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008; 17:R116-21.
3. Plenge RM, Cotsapas C, Davies L et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007;39:1477-82.
4. Remmers EF, Plenge RM, Lee AT et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-86.
5. Thomson W, Barton A, Ke X et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007;39:1431-3.
6. Graham RR, Cotsapas C, Davies L et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008;40:1059-61.
7. Musone SL, Taylor KE, Lu TT et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008;40: 1062-4.
8. Fung EY, Smyth DJ, Howson JM et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009;10:188-91.
9. Plenge RM. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr Opin Rheumatol 2009;21:262-71.
10. Lee YH, Rho YH, Choi SJ et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 2007;46:49-56.
11. Plenge RM, Padyukov L, Remmers EF et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005;77:1044-60.
12. Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75:330-7.
13. Kyogoku C, Langefeld CD, Ortmann WA et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004;75:504-7.
14. Ladner MB, Bottini N, Valdes AM, Noble JA. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 2005; 66:60-4.
15. Sigurdsson S, Nordmark G, Goring HH et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005;76:528-37.
16. Graham RR, Kozyrev SV, Baechler EC et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38: 550-5.
17. Sigurdsson S, Padyukov L, Kurreeman FA et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007;56:2202-10.
18. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-64.
19. Smyth DJ, Plagnol V, Walker NM et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-77.
20. Hafler JP, Maier LM, Cooper JD et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009;10:5-10.
21. Dardalhon V, Schubart AS, Reddy J et al. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol 2005;175:1558-65.
22. Tao D, Shangwu L, Qun W et al. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol 2005;174:1281-90.
23. Nath SK, Han S, Kim-Howard X et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008;40:152-4.
24. Han S, Kim-Howard X, Deshmukh H et al. Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within itgam and systemic lupus erythematosus (SLE). Hum Mol Genet 2009;18:1171-80.
25. Ikari K, Momohara S, Inoue E et al. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology 2006;45: 1345-8.
26. Shin HD, Kim I, Choi CB, Lee SO, Lee HW, Bae SC. Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population. J Rheumatol 2008;35:2148-51.
27. Ito I, Kawaguchi Y, Kawasaki A et al. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum 2009; 60:1845-50.
28. Fernando MM, Stevens CR, Walsh EC et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008;4:e1000024.
29. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-54.
30. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
31. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
32. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554-8.
33. Delgado-Vega AM, Castiblanco J, Gomez LM, Diaz-Gallo LM, Rojas-Villarraga A, Anaya JM. BCL2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann Rheum Dis, Advance Access published March 11, 2009, doi:10.1136/ard.2008.100818.
34. Anaya JM, Castiblanco J, Tobon GJ et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 2006;26:208-14.
35. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
36. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
37. Nicodemus KK. Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics 2008;9:130.
38. Douroudis K, Nemvalts V, Rajasalu T, Kisand K, Uibo R. The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens 2009;74:417-9.
39. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-13.
40. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009;10: 11-4.
41. Wieczorek S, Hoffjan S, Chan A et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009;10: 591-5.
42. Bravo ML, Valenzuela CY, Arcos-Burgos OM. Polymorphisms and phyletic relationships of the Paisa community from Antioquia (Colombia). Gene Geogr 1996; 10:11-7.
43. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of sev-en common diseases and 3,000 shared controls. Nature 2007;447:661-78.
44. Jimenez-Morales S, Velazquez-Cruz R, Ramirez-Bello J et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol 2009;70:251-6.